Sunbiosmith Pharmaceuticals Private Limited
About Sunbiosmith Pharmaceuticals Private Limited
Data last updated:
Sunbiosmith Pharmaceuticals Private Limited is a private limited company based in Dehradun, Uttarakhand, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 23 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U74999UR2018PTC008583.
The company has an authorised share capital of ₹27 Lakh and a paid-up capital of ₹27 Lakh. It is led by directors Sanjay Kumar (Managing Director) and Vibha Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H/O Susheel Sharma S/O Sarveswar Dutt Calcutta Mohallabalawala, Dehradun, Uttarakhand, India – 248001.
As per the financials filed for FY 2025, the company reported a revenue of ₹34.24 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹41,120 (net margin 1.2%) and EBITDA of ₹76,150 (EBITDA margin 2.2%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 21% over five years.
As per MCA filings, the company has open charges of ₹6 Lakh on record.
Company details
Contact details
Sunbiosmith Pharmaceuticals Private Limited's registered office is in Dehradun, Uttarakhand.
- Registered AddressH/O Susheel Sharma S/O Sarveswar Dutt Calcutta Mohallabalawala, Dehradun, Uttarakhand, India – 248001
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sunbiosmith Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sunbiosmith Pharmaceuticals Private Limited, buy the company report.
Financials of Sunbiosmith Pharmaceuticals Private Limited
FY 2025 filings availableSunbiosmith Pharmaceuticals Private Limited reported revenue of ₹34.24 Lakh (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 6% growth in the latest year. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76,150 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41,120 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.2% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunbiosmith Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sunbiosmith Pharmaceuticals Private Limited
Sunbiosmith Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar | Managing Director | 23 Mar 2018 | 8 Years 7 Months | Current |
| Vibha Kumari | Director | 23 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Sunbiosmith Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gurshyam Formulations Private Limited | ₹34.33 Lakh (FY 2024) | -37.0% | Saharanpur, Uttar Pradesh, India | |||
| Smega Pharmaceuticals Private Limited | ₹34.32 Lakh (FY 2019) | -41.0% | Belapur, Maharashtra, India | |||
| Smithsante Pharmaceuticals Private Limited | ₹34.25 Lakh (FY 2024) | 34.0% | Chennai, Tamil Nadu, India | |||
| Sunbiosmith Pharmaceuticals Private Limitedthis company | ₹34.24 Lakh (FY 2025) | ₹41,120 | 1.2% | 6.0% | Dehradun, Uttarakhand, India | |
| Goodness Pharmaceuticals Private Limited | ₹34.21 Lakh (FY 2022) | 6.0% | Aligarh, Uttar Pradesh, India | |||
| Craicean Pharmaceuticals Private Limited | ₹34.19 Lakh (FY 2024) | 8.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Sunbiosmith Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Jun 2025 | 101106727 | State Bank of India | ₹6 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sunbiosmith Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sunbiosmith Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sunbiosmith Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sunbiosmith Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Sanjay Kumar was appointed as Managing Director on 23 Mar 2018.
Frequently asked questions
Sunbiosmith Pharmaceuticals is an active private limited company based in Dehradun, Uttarakhand, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 23 March 2018 (8+ years old) and is registered under CIN U74999UR2018PTC008583.
Sunbiosmith Pharmaceuticals has 2 current directors:
- Sanjay Kumar - Managing Director
- Vibha Kumari - Director
The latest financial statements of Sunbiosmith Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Sunbiosmith Pharmaceuticals is U74999UR2018PTC008583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunbiosmith Pharmaceuticals was incorporated on 23 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Sunbiosmith Pharmaceuticals by revenue are Gurshyam Formulations Private Limited, Smega Pharmaceuticals Private Limited, Smithsante Pharmaceuticals Private Limited, Goodness Pharmaceuticals Private Limited, Craicean Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Sanjay Kumar was appointed as Managing Director on 23 Mar 2018. Vibha Kumari was appointed as Director on 23 Mar 2018.
The registered office of Sunbiosmith Pharmaceuticals is at HO Susheel Sharma SO Sarveswar Dutt Calcutta Mohallabalawala, Dehradun, Uttarakhand, India – 248001.
Sunbiosmith Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Sunbiosmith Pharmaceuticals has open charges of ₹6 Lakh and no satisfied charges on record as per latest MCA filings.
Sunbiosmith Pharmaceuticals can be reached at its registered office: HO Susheel Sharma SO Sarveswar Dutt Calcutta Mohallabalawala, Dehradun, Uttarakhand, India – 248001.